Cleared Traditional

K891135 - PHADIATOP PAEDIATRIC RIA AND EIA

K891135 is the FDA 510(k) clearance for PHADIATOP PAEDIATRIC RIA AND EIA by Pharmacia, Inc.. It is a Class 2 Immunology device (product code DHB) cleared through the Traditional 510(k) pathway after a 67-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1989
Decision
67d
Days
Class 2
Risk

K891135 is an FDA 510(k) clearance for the PHADIATOP PAEDIATRIC RIA AND EIA. Classified as System, Test, Radioallergosorbent (rast) Immunological (product code DHB), Class II - Special Controls.

Submitted by Pharmacia, Inc. (Piscataway, US). The FDA issued a Cleared decision on May 9, 1989 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5750 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pharmacia, Inc. devices

Submission Details

510(k) Number K891135 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 1989
Decision Date May 09, 1989
Days to Decision 67 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 104d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DHB System, Test, Radioallergosorbent (rast) Immunological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHB System, Test, Radioallergosorbent (rast) Immunological

All 187
Devices cleared under the same product code (DHB) and FDA review panel - the closest regulatory comparables to K891135.
CIBA CORNING MAGIC LITE SQ SPECIFIC IGE ASSAY
K896592 · Ciba Corning Diagnostics Corp. · Dec 1989
QUIDEL FOOD ALLERGEN SCREEN
K894253 · Quidel Corp. · Jul 1989
PHADEBAS RAST(R)/PHADEZYM(R) RAST ALLERGEN DISC
K893132 · Pharmacia, Inc. · Jun 1989
QUIDEL FOOD ALLERGEN SCREEN - BARLEY ALLERGEN
K892409 · Quidel Corp. · May 1989
QUIDEL FOOD ALLERGY SCREEN
K884501 · Quidel Corp. · Feb 1989
28 ADDITIONAL ALLERGEN MODULES FOR ALASTAT(TM)
K884883 · Diagnostic Products Corp. · Jan 1989